OMIDRIA
Peakphenylephrine and ketorolac
NDAIRRIGATIONSOLUTION
Approved
May 2014
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
OMIDRIA (phenylephrine and ketorolac) is cyclooxygenase inhibitors [moa]. First approved in 2014.
Drug data last refreshed 5d ago
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
External Resources
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.